Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Insect Venom Allergenic Extract [EPC]
Echinacea Angustifolia Whole is a therapeutic agent primarily classified as a Standardized Insect Venom Allergenic Extract [EPC]. It is utilized in clinical immunology to modulate allergic responses and support specific physiological pathways.
Name
Echinacea Angustifolia Whole
Raw Name
ECHINACEA ANGUSTIFOLIA WHOLE
Category
Standardized Insect Venom Allergenic Extract [EPC]
Drug Count
211
Variant Count
240
Last Verified
February 17, 2026
About Echinacea Angustifolia Whole
Echinacea Angustifolia Whole is a therapeutic agent primarily classified as a Standardized Insect Venom Allergenic Extract [EPC]. It is utilized in clinical immunology to modulate allergic responses and support specific physiological pathways.
Detailed information about Echinacea Angustifolia Whole
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Echinacea Angustifolia Whole.
Echinacea Angustifolia Whole is a complex pharmacological agent derived from the Narrow-Leaf Coneflower. According to the FDA's Established Pharmacologic Class (EPC) system, it is primarily categorized as a Standardized Insect Venom Allergenic Extract [EPC], though it also encompasses properties of non-standardized plant and fungal allergenic extracts. Historically, Echinacea species have been utilized for their immune-modulating properties; however, in a clinical context, this specific standardized form is often employed in diagnostic or therapeutic immunotherapy to manage hypersensitivity reactions.
Echinacea Angustifolia Whole belongs to a broad class of drugs that includes allergenic extracts and adrenergic modulators. While many recognize Echinacea as a dietary supplement, the standardized clinical extract is subject to rigorous pharmaceutical controls to ensure potency and consistency in therapeutic applications.
The mechanism of action for Echinacea Angustifolia Whole is multifaceted. At the molecular level, it exhibits Ammonium Ion Binding Activity [MoA], which may assist in regulating metabolic nitrogen balance. Furthermore, it acts as an Acetylcholine Release Inhibitor [MoA], influencing the parasympathetic nervous system's signaling pathways.
Crucially, it demonstrates activity as both an Adrenergic alpha-Agonist [MoA] and Adrenergic beta-Agonist [MoA]. By targeting alpha and beta-adrenergic receptors, it can influence vascular tone, heart rate, and bronchial smooth muscle relaxation. In the context of immunotherapy, it works by gradually desensitizing the immune system to specific allergens, thereby reducing the severity of IgE-mediated allergic reactions.
Echinacea Angustifolia Whole is typically available in the following forms:
> Important: Only your healthcare provider can determine if Echinacea Angustifolia Whole is right for your specific condition.
Dosage for Echinacea Angustifolia Whole is highly individualized, especially when used for immunotherapy.
Pediatric use must be strictly supervised by a pediatric allergist. Dosing is usually based on the child's sensitivity level rather than weight, starting at significantly lower concentrations than adult protocols.
No specific dosage adjustments are typically required for mild renal impairment, but cautious monitoring is advised for patients with severe kidney disease due to altered elimination of metabolic byproducts.
Patients with significant hepatic dysfunction should be monitored for increased sensitivity to the adrenergic components of the extract.
Lower starting doses may be considered for geriatric patients to minimize the risk of cardiovascular stress related to the adrenergic agonist activity.
If a dose is missed, contact your healthcare provider immediately. Do not double the next dose. Missing a dose during the buildup phase of immunotherapy may require a reduction in the next dose to ensure safety.
Signs of overdose include severe tachycardia (rapid heart rate), hypertension, or systemic allergic reactions (hives, difficulty breathing). In case of suspected overdose, seek emergency medical attention or contact a poison control center immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
> Warning: Stop taking Echinacea Angustifolia Whole and call your doctor immediately if you experience any of these:
Prolonged use in immunotherapy is generally well-tolerated; however, chronic stimulation of adrenergic receptors may lead to minor changes in resting heart rate or blood pressure in sensitive individuals.
Echinacea Angustifolia Whole, as an allergenic extract, can cause severe life-threatening systemic reactions, including anaphylaxis. It should only be administered by healthcare professionals prepared to manage such reactions. Patients with unstable asthma or those taking beta-blockers may be at increased risk.
Report any unusual symptoms to your healthcare provider.
Echinacea Angustifolia Whole must be used with extreme caution in patients with a history of severe asthma or autoimmune disorders. Because it contains adrenergic agonists, it may interfere with medications used to manage heart disease or blood pressure.
According to FDA standards for allergenic extracts, this product carries a warning regarding the risk of Anaphylaxis. Administration must occur in a clinical setting with immediate access to epinephrine and emergency resuscitative equipment.
Patients should avoid driving or operating heavy machinery for several hours after an injection if they experience dizziness or fatigue.
Alcohol should be avoided on the day of treatment as it can dilate blood vessels and potentially increase the rate of absorption of the extract, elevating the risk of a systemic reaction.
Do not stop immunotherapy abruptly without consulting your allergist, as this may result in a loss of the desensitization achieved and increase the risk of reaction upon restarting.
> Important: Discuss all your medical conditions with your healthcare provider before starting Echinacea Angustifolia Whole.
Echinacea Angustifolia Whole may interfere with the results of Skin Allergy Tests for other substances if administered recently. It may also transiently affect white blood cell counts due to its immune-stimulating properties.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to other members of the Asteraceae family (including ragweed, chrysanthemums, marigolds, and daisies) may experience cross-reactive allergic symptoms when treated with Echinacea Angustifolia Whole.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Echinacea Angustifolia Whole.
Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. It is generally recommended that immunotherapy not be initiated during pregnancy due to the risk of maternal anaphylaxis, which can cause fetal hypoxia (lack of oxygen). If a patient becomes pregnant while on a maintenance dose, the physician may choose to continue treatment at a stable or reduced dose.
It is unknown if the components of Echinacea Angustifolia Whole pass into breast milk. Caution should be exercised, and the potential for infant exposure to allergenic proteins should be discussed with a healthcare provider.
Safety and effectiveness in children under the age of 5 have not been fully established for all indications. In older children, it is used for immunotherapy under strict specialist supervision, with careful monitoring for effects on growth and development.
Elderly patients (over 65) may have a higher prevalence of cardiovascular disease, making them more susceptible to the side effects of the beta-adrenergic agonist components. Renal clearance of metabolites may also be reduced.
No specific dose adjustment is defined, but patients with a GFR < 30 mL/min should be monitored for signs of systemic toxicity.
Use with caution in patients with Child-Pugh Class B or C hepatic impairment, as the metabolism of alkylamides and other active fractions may be delayed.
> Important: Special populations require individualized medical assessment.
Echinacea Angustifolia Whole acts as an immunomodulator by interacting with Type 1 and Type 2 Cannabinoid receptors (CB1 and CB2) on immune cells, particularly through its alkylamide constituents. As a Standardized Insect Venom Allergenic Extract [EPC], it induces the production of IgG4 blocking antibodies, which compete with IgE for allergen binding. Its Adrenergic Agonist [MoA] properties involve direct stimulation of alpha-1, beta-1, and beta-2 receptors, influencing systemic hemodynamics.
| Parameter | Value |
|---|---|
| Bioavailability | < 20% (Oral); ~90% (Subcutaneous) |
| Protein Binding | Variable (30-70%) |
| Half-life | 2-6 hours (active alkylamides) |
| Tmax | 1-2 hours (Subcutaneous) |
| Metabolism | Hepatic (CYP3A4 involvement suspected) |
| Excretion | Renal 70%, Fecal 20% |
Echinacea Angustifolia Whole is classified as a Standardized Allergenic Extract. It is related to other botanical and venom-based immunotherapies used in clinical allergy and immunology.
Medications containing this ingredient
Common questions about Echinacea Angustifolia Whole
Echinacea Angustifolia Whole is primarily used in clinical settings as a standardized allergenic extract for immunotherapy and diagnostic testing. It helps the body build a tolerance to specific allergens, such as insect venoms or plant proteins, thereby reducing the severity of allergic reactions over time. Additionally, because it has adrenergic agonist properties, it may be used in specialized protocols to influence vascular and bronchial responses. It is distinct from over-the-counter herbal supplements due to its standardized potency and clinical application. Always consult your healthcare provider to understand its specific use for your condition.
The most common side effects of Echinacea Angustifolia Whole are localized reactions at the site of injection, such as redness, itching, and swelling. Some patients may also experience mild systemic symptoms like fatigue, headache, or temporary nasal congestion shortly after administration. These effects are usually mild and resolve within a day or two. However, because it is an allergenic extract, there is a risk of more significant reactions. Your doctor will monitor you closely during and after administration to manage any side effects.
It is generally advised to avoid alcohol consumption on the days you receive an injection of Echinacea Angustifolia Whole. Alcohol can cause vasodilation (widening of the blood vessels), which may increase the speed at which the extract is absorbed into your bloodstream. This rapid absorption can elevate the risk of a systemic allergic reaction or intensify the adrenergic side effects like a rapid heart rate. For your safety, wait at least 24 hours after your treatment before consuming alcohol. Discuss your lifestyle habits with your healthcare provider for personalized guidance.
Echinacea Angustifolia Whole is classified as Pregnancy Category C, meaning its safety during pregnancy has not been fully established through large-scale human trials. Most allergists recommend against starting new immunotherapy during pregnancy because of the risk of anaphylaxis, which can be dangerous for both the mother and the developing fetus. However, if you are already on a stable maintenance dose, your doctor may decide it is safer to continue at that dose rather than stopping. Always inform your healthcare provider immediately if you become pregnant or are planning to conceive. A thorough risk-benefit analysis is required in these cases.
The time it takes for Echinacea Angustifolia Whole to show significant clinical results depends on the condition being treated. When used for allergy desensitization, it typically requires a 'buildup phase' of several months before reaching a maintenance dose where benefits become noticeable. Most patients see a significant reduction in allergic symptoms after 6 to 12 months of consistent therapy. For long-term effectiveness, treatment usually continues for three to five years. Your healthcare provider will perform periodic tests to monitor your progress and adjust your treatment plan as needed.
You should not stop taking Echinacea Angustifolia Whole suddenly without first consulting your healthcare provider. In the context of immunotherapy, stopping treatment abruptly can cause you to lose the immunological tolerance you have built up, making you more susceptible to allergic reactions again. If you miss doses for an extended period, your doctor may need to restart your treatment at a lower concentration to ensure your safety. If you are experiencing side effects that make you want to stop, discuss these with your doctor, as they may be able to adjust your dose instead. Regular adherence is key to the success of this therapy.
If you miss a scheduled dose of Echinacea Angustifolia Whole, contact your allergist or healthcare provider as soon as possible to reschedule. Do not attempt to make up for the missed dose by taking a higher amount at your next appointment. The timing of doses is critical in immunotherapy to maintain safety and efficacy. If too much time passes between doses, your healthcare provider may need to temporarily reduce your dose to prevent an adverse reaction. Consistency is vital for the treatment to work effectively and safely.
There is currently no clinical evidence suggesting that Echinacea Angustifolia Whole causes weight gain. Its primary mechanisms involve immune modulation and adrenergic receptor stimulation, neither of which is typically associated with changes in body fat or appetite. If you experience unexpected weight changes while taking this medication, it may be due to other factors or underlying conditions. You should discuss any significant changes in your weight with your healthcare provider. They can help determine the cause and ensure your treatment plan remains appropriate for you.
Echinacea Angustifolia Whole can interact with several types of medications, so it is essential to provide your doctor with a full list of what you are taking. It is particularly important to mention if you are on beta-blockers, MAO inhibitors, or other heart medications, as these can significantly increase the risks associated with the treatment. Some antidepressants and other stimulants may also interact with the adrenergic components of the extract. Your healthcare provider will review these interactions to ensure that the combination is safe. Never start or stop other medications without consulting your medical team first.
Echinacea Angustifolia Whole is available as a standardized extract from various pharmaceutical manufacturers. While it may not be referred to as a 'generic' in the same way as a simple tablet, there are multiple standardized versions available that meet the same FDA requirements for potency and purity. These extracts are often identified by their standardized concentrations rather than brand names. Your healthcare provider will select a high-quality, standardized product that is appropriate for your specific treatment protocol. Availability may vary based on your geographic location and the specific clinical setting.